• Glioblastoma brain cancer (GBM) is the most dangerous and aggressive form of brain cancer.

  • GBM is classified as a grade IV astrocytoma.

  • GBM cells grow rapidly, with large number of cells reproducing at any given time. As a tumor grows, it leads to pressure on the brain, causing symptoms such as headaches, nausea, vomiting, and drowsiness.

  • GBM is challenging to treat because the cells within the tumor are very resistant to treatments. Doctors may try a variety of treatments to slow the growth of the tumor, but a cure and/or long term treatment options are still needed.

  • An estimated 86,970 new cases of primary malignant and non-malignant brain and other CNS tumors are expected to be diagnosed in the United States in 2019, 81% of malignant brain tumors are gliomas.

  • An estimated 16,830 people will die from malignant brain tumors (brain cancer) in 2019.

  • For newly diagnosed GBM patients, the median progression free survival is 6.9 months, and median overall survival is 14.6 months.